|
Sections |
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 2 | 7 |
| 1.1 List of Tables | 6 | 2 |
| 1.2 List of Figures | 8 | 1 |
| 2 Introduction | 9 | 1 |
| 2.1 What Is This Report About? | 9 | 1 |
| 3 Definitions of Markets Covered in This Report | 10 | 2 |
| 3.1 Drug delivery devices | 10 | 1 |
| 3.2 Inhalation Systems | 10 | 1 |
| 3.2.1 Metered Dose Inhaler | 10 | 1 |
| 3.2.2 Dry powder inhaler | 10 | 1 |
| 3.3 Infusion Systems | 10 | 1 |
| 3.3.1 Infusion pumps | 10 | 1 |
| 3.3.2 Syringe pumps | 10 | 1 |
| 3.3.3 Disposable Infusion sets | 11 | 1 |
| 4 Healthcare Sector Review | 12 | 8 |
| 4.1 Healthcare Expenditure | 12 | 2 |
| 4.2 Healthcare Infrastructure | 14 | 5 |
| 4.3 Healthcare Policy | 19 | 1 |
| 5 Regulation System | 20 | 7 |
| 5.1 Medical Equipment Approval Process | 20 | 1 |
| 5.1.1 Classification | 20 | 1 |
| 5.2 Pre-market Approval | 21 | 5 |
| 5.3 Fast-track Approval | 26 | 1 |
| 5.4 Registration Period | 26 | 1 |
| 5.5 Labeling and Packaging | 26 | 1 |
| 5.6 Post-market Surveillance | 26 | 1 |
| 6 Pricing and Reimbursement | 27 | 2 |
| 6.1 Reimbursement Application | 27 | 1 |
| 6.2 Reimbursement Systems | 27 | 2 |
| 7 Distribution Structure | 29 | 1 |
| 8 Drug Delivery Devices In Taiwan | 30 | 10 |
| 8.1 Drug Delivery Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015 | 30 | 2 |
| 8.2 Drug Delivery Devices, Taiwan, Overall Revenue ($ mn), 2000-2015 | 32 | 4 |
| 8.3 Drug Delivery Devices, Taiwan, Category Volume (Units), 2000-2015 | 36 | 3 |
| 8.4 Drug Delivery Devices, Taiwan, Company Share (2007-2008) | 39 | 1 |
| 9 Infusion Systems In Taiwan | 40 | 6 |
| 9.1 Infusion Systems Overall Revenue (2000-2015) | 40 | 2 |
| 9.2 Infusion Systems Overall Volume (2000-2015) | 42 | 1 |
| 9.3 Infusion Systems Average Price (2000-2015) | 43 | 1 |
| 9.4 Infusion Systems Distribution Share (2007-2008) | 44 | 1 |
| 9.5 Infusion Systems, Taiwan, Company Share (2007-2008) | 45 | 1 |
| 10 Inhalation Systems In Taiwan | 46 | 7 |
| 10.1 Inhalation Systems Overall Revenue (2000-2015) | 46 | 2 |
| 10.2 Inhalation Systems Overall Volume (2000-2015) | 48 | 2 |
| 10.3 Inhalation Systems Average Price (2000-2015) | 50 | 1 |
| 10.4 Inhalation Systems Distribution Share (2007-2008) | 51 | 1 |
| 10.5 Inhalation Systems, Taiwan, Company Share (2007-2008) | 52 | 1 |
| 11 Overview of Key Companies in Taiwan Drug Delivery Devices Market | 53 | 12 |
| 11.1 AstraZeneca PLC | 53 | 1 |
| 11.1.1 Company Overview | 53 | 1 |
| 11.2 Boehringer Ingelheim GmbH | 53 | 1 |
| 11.2.1 Company Overview | 53 | 1 |
| 11.3 Baxter International Inc. | 54 | 1 |
| 11.3.1 Company Overview | 54 | 1 |
| 11.4.1 Company Overview | 54 | 1 |
| 11.5 Terumo Corporation | 55 | 1 |
| 11.5.1 Company Overview | 55 | 1 |
| 11.5.2 Terumo Corporation Pipeline Products | 55 | 1 |
| 11.5.2.1 Terumo Corporation Pipeline Products By Equipment Type | 55 | 1 |
| 11.5.2.2 Terumo Corporation Pipeline Products By Development Stage | 55 | 1 |
| 11.5.2.3 Terumo Corporation Pipeline Products By Therapy Area | 56 | 1 |
| 11.5.2.4 Terumo Corporation Pipeline Products By Clinical Trials | 56 | 1 |
| 11.5.2.5 Terumo Corporation Pipeline Products By News Summary | 57 | 1 |
| 11.6 Cardinal Health, Inc. | 58 | 1 |
| 11.6.1 Company Overview | 58 | 1 |
| 11.7 GlaxoSmithKline plc | 59 | 1 |
| 11.7.1 Company Overview | 59 | 1 |
| 11.8 B. Braun Melsungen AG | 60 | 1 |
| 11.8.1 Company Overview | 60 | 1 |
| 11.9 Smiths Medical | 60 | 1 |
| 11.9.1 Company Overview | 60 | 1 |
| 11.10 Fresenius Kabi AG | 61 | 1 |
| 11.10.1 Company Overview | 61 | 1 |
| 11.11 Consort Medical plc | 62 | 1 |
| 11.11.1 Company Overview | 62 | 1 |
| 11.11.2 Consort Medical plc Pipeline Products | 62 | 1 |
| 11.11.2.1 Bespak plc Pipeline Products By Equipment Type | 62 | 1 |
| 11.11.2.2 Bespak plc Pipeline Products By Development Stage | 62 | 1 |
| 11.11.2.3 Bespak plc Pipeline Products By Therapy Area | 63 | 1 |
| 11.12 Hospira, Inc. | 64 | 1 |
| 12 Financial Deals Landscape | 65 | 2 |
| 12.1 Partnerships | 65 | 1 |
| 12.1.1 Novartis Terminates Its Licensing Agreement With NexMed | 65 | 1 |
| 12.1.2 Teikoku Pharma Enters Into An Agreement With Eisai | 66 | 1 |
| 13 Appendix | 67 | 5 |
| 13.1 Global Markets Direct Research Methodology | 67 | 1 |
| 13.2 Secondary Research | 68 | 1 |
| 13.3 Primary Research | 68 | 1 |
| 13.4 Models | 69 | 1 |
| 13.5 Forecasts | 69 | 1 |
| 13.6 Expert Panel Validation | 69 | 1 |
| 13.7 Currency Conversion | 70 | 1 |
| 13.8 Contact Us | 71 | 1 |
| 13.9 Disclaimer | 71 | 1 |